4.6 Article

Validity of the 6 min walk test in prediction of the anaerobic threshold before major non-cardiac surgery

期刊

BRITISH JOURNAL OF ANAESTHESIA
卷 108, 期 1, 页码 30-35

出版社

ELSEVIER SCI LTD
DOI: 10.1093/bja/aer322

关键词

anaerobic threshold; exercise test; oxygen consumption; preoperative care

资金

  1. James Cook University Hospital
  2. Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish
  3. ESRC [ES/G007470/1] Funding Source: UKRI

向作者/读者索取更多资源

Background. For perioperative risk stratification, a robust, practical test could be used where cardiopulmonary exercise testing (CPET) is unavailable. The aim of this study was to assess the utility of the 6 min walk test (6MWT) distance to discriminate between low and high anaerobic threshold (AT) in patients awaiting major non-cardiac surgery. Methods. In 110 participants, we obtained oxygen consumption at the AT from CPET and recorded the distance walked (in m) during a 6MWT. Receiver operating characteristic (ROC) curve analysis was used to derive two different cut-points for 6MWT distance in predicting an AT of <11 ml O-2 kg(-1) min(-1); one using the highest sum of sensitivity and specificity (conventional method) and the other adopting a 2:1 weighting in favour of sensitivity. In addition, using a novel linear regression-based technique, we obtained lower and upper cut-points for 6MWT distance that are predictive of an AT that is likely to be (P >= 0.75) <11 or >11 ml O-2 kg(-1) min(-1). Results. The ROC curve analysis revealed an area under the curve of 0.85 (95% confidence interval, 0.77-0.91). The optimum cut-points were <440 m (conventional method) and <502 m (sensitivity-weighted approach). The regression-based lower and upper 6MWT distance cut-points were <427 and >563 m, respectively. Conclusions. Patients walking >563 m in the 6MWT do not routinely require CPET; those walking <427 m should be referred for further evaluation. In situations of 'clinical uncertainty' (>= 427 but <= 563 m), the number of clinical risk factors and magnitude of surgery should be incorporated into the decision-making process. The 6MWT is a useful clinical tool to screen and risk stratify patients in departments where CPET is unavailable.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据